Crucial roles of GATA-2 and SP1 in adrenomedullin-affected expression of tissue factor pathway inhibitor in human umbilical vein endothelial cells exposed to lipopolysaccharide

Thrombosis and Haemostasis

Volumn 97, Issue 5, 2007, Pages 839-846

  Liu, Wei ^a   Zhu, Zi Qiang ^a   Wang, Wen ^a   Zu, Shu Yu ^a   Zhu, Guang Jin ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Adrenomedullin; Human umbilical vein endothelial cells; Tissue factor pathway inhibitor; Transcriptional factor

Indexed keywords

ADRENOMEDULLIN; CALCIUM ANTAGONIST; CYCLIC AMP DERIVATIVE; MESSENGER RNA; TISSUE FACTOR PATHWAY INHIBITOR; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR SP1;

ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION INHIBITION; UMBILICAL VEIN; WESTERN BLOTTING;

ADRENOMEDULLIN; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIAL CELLS; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR;

EID: 34249100244     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-09-0536     Document Type: Article

References (49)

1. Lee YM, et al. Scoparone inhibits tissue factor expression in lipopolysaccharide-activated human umbilical vein endothelial cells. J Biomed Sci 2003; 10: 518-525.
2. Molor-Erdene P et al. Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo. Thromb Haemost 2005; 94: 136-145.
3. Hara S, et al. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation. Lab Invest 1997; 77: 581-589.
4. de Waard V, et al. Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited. Thromb Haemost 2006; 95: 348-353.
5. Mackman N, et al. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol 1993; 143: 76-84.
6. Erlich J, et al. Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun 1999; 67: 2540-2546.
7. Bajaj MS, et al. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA 1990; 87: 8869-8873.
8. Shimokawa T, et al. Down-regulation of murine tissue factor pathway inhibitor mRNA by endotoxin and tumor necrosis factor-alpha in vitro and in vivo. Thromb Res 2000; 100: 211-221.
9. de Jonge E, et al. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood 2000; 95: 1124-1129.
10. Opal SM, et al. The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis. Crit Care Med 2001; 29: 13-17.
11. Kitamura K, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
12. Eto T, et al. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol 1999; 26: 371-380.
13. Cheung BM, et al. Increased adrenomedullin expression in lungs in endotoxaemia. J Endocrinol 2004; 181: 339-345.
14. Nishio K, et al. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone inpatients with septic shock. Crit Care Med 1997; 25: 953-957.
15. Wang P. Adrenomedullin in sepsis and septic shock. Shock 1998; 10: 383-384.
16. Matsui E, et al. Biosynthesis and secretion of adrenomedullin and proadrenomedullin N-terminal 20 peptide in a rat model of endotoxin shock. Hypertens Res 2001; 24: 543-549.
17. Shoji H, et al. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem Biophys Res Commun 1995; 215: 531-537.
18. Agorreta J, et al. Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS. Am J Physiol Lung Cell Mol Physiol 2005; 288: L536-545.
19. Shindo T, et al. Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. J Cardiovasc Pharmacol 1998; 31 (Suppl 1):S541-544.
20. Li YY, et al. Adrenomedullin gene expression and levels in the cardiovascular system after treatment with lipopolysaccharide. Neuropeptides 2005; 39: 73-80.
21. Tomoda Y, et al. Regulation of adrenomedullin secretion from cultured cells. Peptides 2001; 22: 1783-1794.
22. Shindo T, et al. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice over-expressing adrenomedullin in their vasculature. Circulation 2000; 101: 2309-2316.
23. Imai Y, et al. Evidence for the physiological and pathological roles of adrenomedullin from genetic engineering in mice. Ann NY Acad Sci 2001; 947: 26-34.
24. Sugano T, et al. Adrenomedullin inhibits angiotensin II-induced expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Arterioscler Thromb Vasc Biol 2001; 21: 1078-1083.
25. Marutsuka K, et al. Adrenomedullin augments the release and production of tissue factor pathway inhibitor in human aortic endothelial cells. Cardiovasc Res 2003; 57: 232-237.
26. Jaffe EA, et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. Clin Invest 1973; 52: 2745-2756.
27. Simpson P, et al. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982; 51: 787-801.
28. Grynkiewicz G, et al. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450.
29. Chiu JJ, et al. Shear stress attenuates tumor necrosis factor-α-induced monocyte chemotactic protein-1 expressions in endothelial cells. Chin J Physiol 2002; 45: 169-176.
30. Petit L, et al. The promoter of human tissue factor pathway inhibitor gene: identification of potential regulatory elements. Thromb Res 1999; 95: 255-262.
31. Michibata H, et al. Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cells. Kidney Int 1998; 53: 979-985.
32. Tyson DR, et al. Revised DNA sequence of exon 1 and 5′ flanking region of the human tissue factor pathway inhibitor gene. Thromb Res 1993; 70: 269-273.
33. Hamilton G, et al. Endotoxin, TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis. Scand J Infect Dis 1992; 24: 361-368.
34. Wada Y, et al. Preconditioning of primary human endothelial cells with inflammatory mediators alters the "set point" of the cell. FASEB J 2005; 19: 1914-1916.
35. Vignoli A, et al. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties. Haematologica 2006; 91: 207-214.
36. Lee YM, et al. Scoparone inhibits tissue factor expression in lipopolysaccharide-activated human umbilical vein endothelial cells. J Biomed Sci 2003; 10: 518-525.
37. Johnson K, et al. Tbc proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996; 87: 5051-5060.
38. Bucki R, Pastore JJ. Bacterial endotoxin as inhibitor of the enzymatic activity of human thrombin. Eur J Haematol 2006; 76: 510-515.
39. Kano H, et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 1996; 14: 209-213.
40. Hinson JP, et al. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000; 21: 13 8-167.
41. Mazzocchi G, et al. Adrenomedullin and calcitonin gene-related peptide inhibit aldosterone secretion in rats, acting via a common receptor. Life Sci 1996; 58: 839-844.
42. Dannenberg LO, et al. GATA-2 and HNF-3beta regulate the human alcohol dehydrogenase. 1A (ADH1A) gene. DNA Cell Biol 2005; 24: 543-552.
43. Brecht K, et al. Hematopoietic transcription factor GATA-2 promotes upregulation of alpha globin and cell death in FL5.12 cells. Apoptosis 2005; 10: 1063-1078.
44. Minami T, et al. Interaction between hex and GATA transcription factors in vascular endothelial cells inhibits fik-1/KDR-mediated vascular endothelial growth factor signaling. J Biol Chem 2004; 279: 20626-20635.
45. Lee ME, et al. Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem 1991; 266: 16188-16192.
46. Dorfman DM, et al. Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 1992; 267: 1279-1285.
47. Bajaj MS, et al. Role of GATA motifs in tissue factor pathway inhibitor gene expression in malignant cells. Thromb Res 2001; 101: 203-211.
48. Chen YQ, et al. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J Biol Chem 1998; 273: 8225-8231.
49. Tanaka T, et al. Inducible expression of manganese superoxide disimitase by phorbol 12-myristate 13-acetate is mediated by Sp1 in endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20: 392-401.